Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Comment by Moemoney42on Feb 19, 2022 10:43pm
111 Views
Post# 34445746

RE:How testing can be made accessible?

RE:How testing can be made accessible?
Boudi1959 wrote:

On how to make COVID tests accessible, she added, “It needs to be affordable, it needs to be reliable, it needs to be rapid and it needs to be cheap. It needs to be affordable for people to actually be able to use it."

Adding to this, WHO's Mike Ryan said, An antigen test that costs a dollar a piece, may sound very cheap in the industrialised world. But if you’re living in a developing country where you might spend five or ten dollars per person on health for the whole year, five antigen tests or ten antigen tests are massively expensive.


So how much profitability will THRM have, if it has to sell tests at a buck to compete with the big boys..? That will certainly throw a wrench in the business model..!
<< Previous
Bullboard Posts
Next >>